Back to Report Store Home

Type 2 Diabetes Mellitus Therapeutics in South-East Asia Markets to 2022 – Increasing Usage of Newer Therapies and Expanding Treatment Population to Encourage Robust Growth

  • Published: Aug-2016
  • Report Code: GBIHC421MR
  • Report Format: pdf

Description

List of Figures

Figure 1: T2DM Therapeutics Market, South-East Asia, Heat Map for Marketed Products, 2016 72

Figure 2: T2DM Therapeutics Market, South-East Asia, Heat Map for Marketed Products, 2016 (continued) 73

Figure 3: T2DM Therapeutics Market, Global, Pipeline, 2016 75

Figure 4: T2DM Therapeutics Market, Global, Pipeline by Molecular Target, 2016 77

Figure 5: T2DM Therapeutics Market, Global, Pipeline by Molecular Target and Stage of Development, 2016 78

Figure 6: T2DM Therapeutics Market, South-East Asia, NN-9535 Forecast ($m), 2018–2022 82

Figure 7: T2DM Therapeutics Market, South-East Asia, OG-217SC Forecast ($m), 2020–2022 83

Figure 8: T2DM Therapeutics Market, South-East Asia, Trulicity Products Forecast ($m), 2016–2022 85

Figure 9: T2DM Therapeutics Market, South-East Asia, Ertugliflozin Products Forecast ($m), 2018–2022 86

Figure 10: T2DM Therapeutics Market, South-East Asia, Bexagliflozin Products Forecast ($m), 2020–2022 87

Figure 11: T2DM Therapeutics Market, South-East Asia, Omarigliptin Products Forecast ($m), 2017–2022 89

Figure 12: T2DM Market, South-East Asia, Heat Map for Pipeline Products, March 2016 90

Figure 13: T2DM Therapeutics Market, South-East Asia, Competitor Matrix for Marketed and Pipeline Products, March 2016 93

Figure 14: T2DM Therapeutics, Global, Clinical Trial Attrition Rates (%), 2006–March 2016 94

Figure 15: T2DM Therapeutics, Global, Clinical Trial Attrition Rates by Molecule Type (%), 2006–March 2016 95

Figure 16: T2DM Therapeutics, Global, Clinical Trial Attrition Rates by Molecular Target (%), 2006–March 2016 96

Figure 17: T2DM Therapeutics, Global, Clinical Trial Size per Product by Molecule Type (participants), 2006–March 2016 97

Figure 18: T2DM Therapeutics, Global, Clinical Trial Size per Product Molecular Target (participants), 2006–March 2016 98

Figure 19: T2DM Therapeutics, Global, Clinical Trial Size per Individual Trial by Molecule Type (participants), 2006–March 2016 99

Figure 20: T2DM Therapeutics, Global, Clinical Trial Size per Individual Trial by Molecular Target (participants), 2006–March 2016 100

Figure 21: T2DM Therapeutics, Global, Clinical Trial Duration by Molecule Type (months), 2006–March 2016 101

Figure 22: T2DM Therapeutics, Global, Clinical Trial Duration by Molecular Target (months), 2006–March 2016 102

Figure 23: T2DM Therapeutics, Global, Comparison of Average Trial Metrics by Phase and Molecule Type, 2006–March 2016 103

Figure 24: T2DM Therapeutics, Global, Comparison of Average Trial Metrics by Phase and Molecular Target, 2006–March 2016 103

Figure 25: T2DM Therapeutics Market, South-East Asia, Treatment Usage Patterns (million), 2015–2022 105

Figure 26: T2DM Therapeutics Market, South-East Asia, Market Size ($bn), 2015–2022 106

Figure 27: T2DM Therapeutics Market, South Korea, Treatment Usage Patterns (million), 2015–2022 107

Figure 28: T2DM Therapeutics Market, South Korea, Annual Cost of Therapy ($), 2015–2022 108

Figure 29: T2DM Therapeutics Market, South Korea, Market Size ($m), 2015–2022 109

Figure 30: T2DM Therapeutics Market, Singapore, Treatment Usage Patterns (million), 2015–2022 110

Figure 31: T2DM Therapeutics Market, Singapore, Annual Cost of Therapy ($), 2015–2022 110

Figure 32: T2DM Therapeutics Market, Singapore, Market Size ($m), 2015–2022 111

Figure 33: T2DM Therapeutics Market, Taiwan, Treatment Usage Patterns (million), 2015–2022 112

Figure 34: T2DM Therapeutics Market, Taiwan, Annual Cost of Therapy ($), 2015–2022 113

Figure 35: T2DM Therapeutics Market, Taiwan, Market Size ($m), 2015–2022 114

Figure 36: T2DM Therapeutics Market, Malaysia, Treatment Usage Patterns (million), 2015–2022 115

Figure 37: T2DM Therapeutics Market, Malaysia, Annual Cost of Therapy ($), 2015–2022 115

Figure 38: T2DM Therapeutics Market, Malaysia, Market Size ($m), 2015–2022 116

Figure 39: T2DM Therapeutics Market, Philippines, Treatment Usage Patterns (million), 2015–2022 117

Figure 40: T2DM Therapeutics Market, Philippines, Annual Cost of Therapy ($), 2015–2022 117

Figure 41: T2DM Therapeutics Market, Philippines, Market Size ($m), 2015–2022 118

Figure 42: T2DM Therapeutics Market, Thailand, Treatment Usage Patterns (million), 2015–2022 119

Figure 43: T2DM Therapeutics Market, Thailand, Annual Cost of Therapy ($), 2015–2022 120

Figure 44: T2DM Therapeutics Market, Thailand, Market Size ($m), 2015–2022 120

Figure 45: T2DM Therapeutics Market, Vietnam, Treatment Usage Patterns (million), 2015–2022 121

Figure 46: T2DM Therapeutics Market, Vietnam, Annual Cost of Therapy ($), 2015–2022 122

Figure 47: T2DM Therapeutics Market, Vietnam, Market Size ($m), 2015–2022 123

Figure 48: T2DM Therapeutics Market, Indonesia, Treatment Usage Patterns (million), 2015–2022 124

Figure 49: T2DM Therapeutics Market, Indonesia, Annual Cost of Therapy ($), 2015–2022 124

Figure 50: T2DM Therapeutics Market, Indonesia, Market Size ($m), 2015–2022 125

Figure 51: T2DM Therapeutics Market, Global, Licensing Deals by Deal Value, 2006–March 2016 128

Figure 52: T2DM Therapeutics Market, Global, Licensing Deals by Region, 2006–March 2016 129

Figure 53: T2DM Therapeutics Market, Global, Number of Disclosed and Undisclosed Licensing Deals by Year, Aggregate Deal Value ($m) and Aggregate Upfront Value ($m), 2006–March 2016 129

Figure 54: T2DM Therapeutics Market, Global, Licensing Deals by Deal Value ($m), Upfront Payment Value ($m) and Stage of Development, 2006–March 2016 130

Figure 55: T2DM Therapeutics Market, Global, Licensing Deals by Stage of Development, Molecule Type and Aggregate Deal Value ($bn), 2006–March 2016 131

Figure 56: T2DM Therapeutics Market, Global, Licensing Deals by Molecular Target and Aggregate Deal Value ($m), 2006–March 2016 132

Figure 57: T2DM Therapeutics Market, Global, Co-development Deals by Value ($m), 2006–March 2016 134

Figure 58: T2DM Therapeutics Market, Global, Co-Development Deals by Region, 2006–March 2016 134

Figure 59: T2DM Therapeutics Market, Global, Number of Disclosed and Undisclosed Co-Development Deals by Year, Aggregate Deal Value ($m) and Aggregate Upfront Payment Value ($m), 2006–March 2016 135

Figure 60: T2DM Therapeutics Market, Global, Co-development Deals by Deal Value ($m), Upfront Payment Value ($m) and Stage of Development, 2006–March 2016 136

Figure 61: T2DM Therapeutics Market, Global, Co-development Deals by Stage of Development, Molecule Type and Aggregate Deal Value ($bn), 2006–March 2016 138

Figure 62: T2DM Therapeutics Market, Global, Co-Development Deals by Molecular Target and Aggregate Deal Value ($m), 2006–March 2016 139

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$4995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$9990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$14985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards